William Gerard Powderly, MD
- Infectious Diseases
Sees Patients For
Treatment of infectious diseases including HIV and AIDS, fungal infections
Academic Title(s)
J. William Campbell Professor of Medicine, Infectious DiseasesDirector, Institute of Public Health
Director, Institute of Clinical and Translational Sciences
Languages
- English
Education
MB, BCh, BAO1979 University College, Dublin, Ireland
Fellowship, Infectious Diseases1987 Washington University School of Medicine, St. Louis, MO
Residency, Registrar in Medicine1983 Mater Misericordiae Hospital, Dublin, Ireland
Residency, Senior House Officer in Medicine1982 St. Vincent's Hospital, Dublin, Ireland
Research Interests
Improving treatments for patients with HIV; understanding long-term side effects of HIV medications, particularly metabolic problems such as diabetes, lipid abnormalities, and osteoporosis.
Publications & Research
Search PubMed for publications »Financial Disclosures
Disclosure of Financial Interests with Industry
Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.